References

Feldstein, A.C., D.H. Smith, N. Perrin, X. Yang and S.R. Simon et al., 2006. Reducing warfarin medication interactions: An interrupted time series evaluation. Arch. Intern. Med., 166: 1009-1015.
PubMed  |  Direct Link  |  

Ginsberg, J.A., M.A. Crowther, R.A. White and T.L. Ortel, 2001. Anticoagulation therapy. Hematol. Am. Soc. Hematol. Educ. Program., 2001: 339-357.
PubMed  |  Direct Link  |  

Hambleton, J., 2004. Drugs Used in Disorders of Coaguation. In: Basic And Clinical Pharmacology, Katzung, B.G. (Ed.). McGraw-Hill, New York, pp: 543- 560.

Hirsh, J., J.E. Dalen, D.R. Anderson, L. Poller, H. Bussey, J. Ansell and D. Deykin, 2001. Oral anticoagulants: Mechanism of action, clinical effectiveness and optimal therapeutic range. J. Am. Chest Phys., 119: 8S-21S.
Direct Link  |  

Kucher, N., L.R. Castellanos, R. Quiroz, S. Koo, J. Fanikos and S.Z. Goldhaber, 2004. Time trends in warfarin associated hemorrhage. Am. J. Cardiol., 94: 403-406.
PubMed  |  Direct Link  |  

Landefeld, C. and R. Beyth, 1993. Anticoagulant-related bleeding: Clinical epidemiology, prediction and prevention. Am. J. Med., 95: 315-328.

Schulman, S., 2003. Care of patients receiving longterm anticoagulant therapy. N. Engl. J. Med., 34: 675-683.
PubMed  |  Direct Link  |  

Visser, L.E., G.S. Bleumink, P.H. Trienekens, A.G. Vulto, A. Hofman and B.H. Stricker, 2004. The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants. Br. J. Haematol., 127: 85-89.
PubMed  |  Direct Link  |